Vaccine Astrazeneca

Rediff.com » News » Vaccine Astrazeneca

News for Vaccine Astrazeneca

News
Business
Sports

AstraZeneca's COVID-19 Vaccine: The TTS Factor

'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters The controversial......

Siddaramaiah Flags Vaccine-Heart Link

Karnataka Chief Minister Siddaramaiah alleged that the rushed approval and distribution of the COVID-19 vaccine may be a contributing factor to cardiac arrest deaths, citing several international......

AstraZeneca withdraws COVID-19 vaccine globally: Report

United Kingdom-based pharmaceutical major AstraZeneca has started global withdrawal of its COVID-19 vaccine, which was provided in India as 'Covishield' in partnership with Serum Institute of......

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......

AstraZeneca admits in court: Covishield causes TTS

United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

'We will price Covid vaccine below Rs 1,000'

'Once the trials are successful in India and the UK, we are certain that COVISHIELD will be one of the first vaccines to be introduced.' IMAGE: The Reference Center for Special Immunobiologicals......

MNCs look towards India for a booster dose

In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......

Serum Institute to provide Covid vaccine at Rs 250 a dose

Serum Institute of India plans to make 300 million doses of AZD1222 by December, and will begin phase-2 trials soon. It has also tied up with Novavax for development and commercialisation of its......

Meet Adar Poonawala, India's COVID-19 vaccine man

Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......

SEE: Gayle thanks PM Modi for sending COVID vaccine to Jamaica

IMAGE: West Indies batsman Chris Gayle. Photograph: BCCI West Indies batsman Chris Gayle thanked Prime Minister Narendra Modi for helping Jamaica by providing COVID-19 vaccines under the Vaccine......

Vaccine Astrazeneca

News for Vaccine Astrazeneca

AstraZeneca's COVID-19 Vaccine: The TTS Factor

Siddaramaiah Flags Vaccine-Heart Link

AstraZeneca withdraws COVID-19 vaccine globally: Report

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

AstraZeneca admits in court: Covishield causes TTS

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

'We will price Covid vaccine below Rs 1,000'

MNCs look towards India for a booster dose

Serum Institute to provide Covid vaccine at Rs 250 a dose

Meet Adar Poonawala, India's COVID-19 vaccine man

SEE: Gayle thanks PM Modi for sending COVID vaccine to Jamaica

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS